Research Article
Diagnostic Potential of Evaluation of SDF-1α and sRAGE Levels in Threatened Premature Labor
Table 4
Descriptive statistics of the study groups.
| | Parameter | Group A, preterm labor | Group B, term labor | | Min–max | Q1 | Q3 | Median | | Min–max | Q1 | Q3 | Median |
| | WBC (109/L) | 72 | 3.32–25.4 | 9.96 | 14.4 | 12.0 | 65 | 7.14–21.08 | 9.97 | 14.0 | 11.9 | | CRP (mg/L) | 72 | 0.3–19.0 | 1.5 | 4.9 | 3.0 | 65 | 0.2–77.3 | 2.7 | 11.8 | 5.8 | | SDF-1α (pg/mL) | 72 | 1000–5515 | 1553 | 2418 | 2031 | 65 | 1018–5362 | 1836 | 3128 | 2374 | | RE (pg/mL) | 72 | 3958–52950 | 6787 | 11180 | 8214 | 65 | 3277–131800 | 7022 | 14640 | 9739 | | sRAGE (pg/mL) | 72 | 48.9–4872 | 333.2 | 683.4 | 456.0 | 65 | 77.4–1787.7 | 458.4 | 882.9 | 736.9 | | esRAGE (pg/mL) | 72 | 230.0–958.8 | 463.05 | 604.7 | 526.6 | 65 | 345.0–1096.8 | 472.1 | 599.2 | 532.1 |
|
|
WBC: white blood cells; CRP: C-reactive protein; SDF-1α: stromal cell-derived factor-1α; RE: resistin; sRAGE: secretory receptors for advanced glycation end products; esRAGE: endogenous secretory receptors for advanced glycation end products; Q1: quartile 1; Q3: quartile 3; min: minimum; max: maximum.
|
